Aclaris Therapeutics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Aclaris Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 5% to $31,249,000. The net income raised on -$88,481,000 and profit margin reached -283%. Total operating expenses were $130,796,000.

Profit Margin

Aclaris Therapeutics, Inc. (NASDAQ:ACRS): Profit margin
2014 0 -8.51M
2015 0 -20.56M
2016 0 -48.07M
2017 1.68M -68.52M -4071.48%
2018 10.09M -132.73M -1315.41%
2019 4.22M -142.85M -3379.47%
2020 6.48M -51.15M -789.17%
2021 6.76M -114.28M -1690.3%
2022 29.75M -88.66M -298%
2023 31.24M -88.48M -283.15%

ACRS Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
31.24M29.75M6.76M6.48M4.22M10.09M1.68M000
Cost of revenue
18.08M11.96M4.71M5.13M4.05M6.85M1.20M090K0
Gross profit
13.16M17.79M2.04M1.34M172K3.24M476K0-90K0
Operating exp.
Research and development
98.38M77.81M43.81M31.73M64.89M63.00M39.79M33.47M15.33M6.50M
Selling and marketing
000283K671K47.99M85K000
Total operating expenses
130.79M102.94M67.43M52.26M92.72M138.65M72.89M48.56M20.66M8.53M
Operating income
-97.35M-85.15M-65.38M-50.91M-111.05M-135.41M-72.42M-48.56M-20.66M-8.53M
Other income (expenses), net
8.50M-1.75M-25.48M-424K-2.48M2.67M-15.99M488K104K16K
Income before tax
-88.84M-86.90M-90.86M-51.33M-113.54M-132.73M-70.35M-48.07M-20.56M-8.51M
Income tax expense
-367K1.75M23.41M-182K29.30M2.67M-1.83M-120K-90K0
Net income
-88.48M-88.66M-114.28M-51.15M-142.85M-132.73M-68.52M-48.07M-20.56M-8.51M
Earnings per share
Basic EPS
-1.27-1.36-2.01-1.2-3.46-4.03-2.44-2.25-3.37-0.8
Diluted EPS
-1.27-1.36-2.01-1.2-3.46-4.03-2.44-2.25-3.37-0.8
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source